ABX Advanced Biochemical Compounds GmbH

ABX advanced biochemical compounds, established in 1997 and headquartered in Radeberg, Germany, leads the industry in radiopharmaceuticals focusing on positron emission tomography (PET) tracers. With a workforce of approximately 400 professionals, the company specializes in the custom synthesis and manufacturing of various precursors and peptides adhering to Good Manufacturing Practice (GMP) standards, ensuring the production of active pharmaceutical ingredients of the highest quality. ABX`s comprehensive product range includes PET and SPECT precursors, reagent kits, cassettes, and complete radiopharmaceutical drugs, leveraging cutting-edge technology to meet stringent research, production, and quality standards. Notably, ABX distinguishes itself as the sole radiopharmaceutical production service provider with a full and independent supply chain, encompassing all components from precursors to sterile disposables.